JNJ
JOHNSON & JOHNSONCompany with tickers: JNJ
CIK
200406
CUSIP
478160104
Shares Outstanding
2,407,216,971
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-01 | REED JOHN C | EVP, Innovative Medicine, R&D | Tax | 11,002 |
| 2026-05-01 | REED JOHN C | EVP, Innovative Medicine, R&D | Convert | 25,255 |
| 2026-05-01 | REED JOHN C | EVP, Innovative Medicine, R&D | Convert | 25,255 |
| 2026-04-23 | Johnson Paula A | Director | Award | 975 |
| 2026-04-23 | HEWSON MARILLYN A | Director | Award | 975 |
| 2026-04-23 | Beckerle Mary C | Director | Award | 975 |
| 2026-04-23 | Woods Eugene A. | Director | Award | 975 |
| 2026-04-23 | West Nadja | Director | Award | 975 |
| 2026-04-23 | WEINBERGER MARK A | Director | Award | 975 |
| 2026-04-23 | Pinto Daniel E | President & COO | Award | 1,712 |
| 2026-04-23 | MORIKIS JOHN G | Director | Award | 1,540 |
| 2026-04-23 | McClellan Mark B. | Director | Award | 975 |
| 2026-04-23 | Joly Hubert | Director | Award | 975 |
| 2026-04-23 | Doudna Jennifer A | Director | Award | 975 |
| 2026-03-10 | HEWSON MARILLYN A | Director | Award | 206 |
| 2026-03-10 | Pinto Daniel E | President & COO | Award | 129 |
| 2026-03-10 | Woods Eugene A. | Director | Award | 154 |
| 2026-02-27 | Decker Robert J | VP Corporate Controller | Sell | 4,075 |
| 2026-02-27 | Decker Robert J | VP Corporate Controller | Other | 134 |
| 2026-02-27 | Decker Robert J | VP Corporate Controller | Convert | 4,075 |
| 2026-02-27 | Decker Robert J | VP Corporate Controller | Other | 646 |
| 2026-02-27 | Decker Robert J | VP Corporate Controller | Convert | 4,075 |
| 2026-02-20 | Schmid Timothy | EVP, WW Chair, MedTech | Sell | 1,322 |
| 2026-02-20 | Schmid Timothy | EVP, WW Chair, MedTech | Other | 46 |
| 2026-02-20 | Schmid Timothy | EVP, WW Chair, MedTech | Other | 745 |
| 2026-02-18 | Schmid Timothy | EVP, WW Chair, MedTech | Sell | 13,625 |
| 2026-02-18 | Schmid Timothy | EVP, WW Chair, MedTech | Convert | 8,998 |
| 2026-02-18 | Schmid Timothy | EVP, WW Chair, MedTech | Sell | 8,998 |
| 2026-02-18 | Schmid Timothy | EVP, WW Chair, MedTech | Convert | 8,998 |
| 2026-02-18 | Schmid Timothy | EVP, WW Chair, MedTech | Convert | 13,625 |
| 2026-02-18 | Schmid Timothy | EVP, WW Chair, MedTech | Convert | 13,625 |
| 2026-02-17 | REED JOHN C | EVP, Innovative Medicine, R&D | Sell | 29,927 |
| 2026-02-17 | REED JOHN C | EVP, Innovative Medicine, R&D | Convert | 21,721 |
| 2026-02-17 | REED JOHN C | EVP, Innovative Medicine, R&D | Convert | 29,927 |
| 2026-02-17 | REED JOHN C | EVP, Innovative Medicine, R&D | Convert | 21,721 |
| 2026-02-17 | REED JOHN C | EVP, Innovative Medicine, R&D | Sell | 21,721 |
| 2026-02-17 | REED JOHN C | EVP, Innovative Medicine, R&D | Convert | 29,927 |
| 2026-02-17 | REED JOHN C | EVP, Innovative Medicine, R&D | Sell | 2,283 |
| 2026-02-17 | Swanson James D. | EVP, CIO | Sell | 20,521 |
| 2026-02-17 | Swanson James D. | EVP, CIO | Convert | 20,521 |
| 2026-02-17 | Swanson James D. | EVP, CIO | Convert | 20,521 |
| 2026-02-17 | Wolk Joseph J | Exec VP, CFO | Sell | 19,241 |
| 2026-02-17 | Wolk Joseph J | Exec VP, CFO | Convert | 12,066 |
| 2026-02-17 | Wolk Joseph J | Exec VP, CFO | Convert | 12,066 |
| 2026-02-17 | Wolk Joseph J | Exec VP, CFO | Sell | 33,386 |
| 2026-02-17 | Wolk Joseph J | Exec VP, CFO | Convert | 19,241 |
| 2026-02-17 | Wolk Joseph J | Exec VP, CFO | Convert | 33,386 |
| 2026-02-17 | Wolk Joseph J | Exec VP, CFO | Convert | 33,386 |
| 2026-02-17 | Wolk Joseph J | Exec VP, CFO | Sell | 12,066 |
| 2026-02-17 | Wolk Joseph J | Exec VP, CFO | Convert | 19,241 |
| 2026-02-17 | Wolk Joseph J | Exec VP, CFO | Sell | 24,961 |
| 2026-02-17 | Broadhurst Vanessa | EVP, Global Corp Affairs | Sell | 6,197 |
| 2026-02-15 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Award | 16,945 |
| 2026-02-15 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Tax | 310 |
| 2026-02-15 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Convert | 606 |
| 2026-02-15 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Convert | 635 |
| 2026-02-15 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Award | 1,217 |
| 2026-02-15 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Convert | 606 |
| 2026-02-15 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Convert | 635 |
| 2026-02-15 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Tax | 325 |
| 2026-02-15 | REED JOHN C | EVP, Innovative Medicine, R&D | Tax | 385 |
| 2026-02-15 | REED JOHN C | EVP, Innovative Medicine, R&D | Award | 49,382 |
| 2026-02-15 | REED JOHN C | EVP, Innovative Medicine, R&D | Tax | 528 |
| 2026-02-15 | REED JOHN C | EVP, Innovative Medicine, R&D | Convert | 1,349 |
| 2026-02-15 | REED JOHN C | EVP, Innovative Medicine, R&D | Convert | 1,847 |
| 2026-02-15 | REED JOHN C | EVP, Innovative Medicine, R&D | Convert | 1,349 |
| 2026-02-15 | REED JOHN C | EVP, Innovative Medicine, R&D | Convert | 1,847 |
| 2026-02-15 | REED JOHN C | EVP, Innovative Medicine, R&D | Award | 3,546 |
| 2026-02-15 | Forminard Elizabeth | EVP, Chief Legal Officer | Convert | 961 |
| 2026-02-15 | Forminard Elizabeth | EVP, Chief Legal Officer | Convert | 961 |
| 2026-02-15 | Swanson James D. | EVP, CIO | Convert | 492 |
| 2026-02-15 | Swanson James D. | EVP, CIO | Tax | 214 |
| 2026-02-15 | Swanson James D. | EVP, CIO | Tax | 309 |
| 2026-02-15 | Swanson James D. | EVP, CIO | Convert | 709 |
| 2026-02-15 | Swanson James D. | EVP, CIO | Convert | 492 |
| 2026-02-15 | Swanson James D. | EVP, CIO | Award | 19,449 |
| 2026-02-15 | Swanson James D. | EVP, CIO | Convert | 709 |
| 2026-02-15 | Swanson James D. | EVP, CIO | Award | 1,397 |
| 2026-02-15 | Mulholland Kristen | EVP, Chief HR Officer | Convert | 575 |
| 2026-02-15 | Mulholland Kristen | EVP, Chief HR Officer | Tax | 251 |
| 2026-02-15 | Mulholland Kristen | EVP, Chief HR Officer | Award | 20,322 |
| 2026-02-15 | Mulholland Kristen | EVP, Chief HR Officer | Convert | 419 |
| 2026-02-15 | Mulholland Kristen | EVP, Chief HR Officer | Tax | 172 |
| 2026-02-15 | Mulholland Kristen | EVP, Chief HR Officer | Convert | 575 |
| 2026-02-15 | Mulholland Kristen | EVP, Chief HR Officer | Convert | 419 |
| 2026-02-15 | Mulholland Kristen | EVP, Chief HR Officer | Award | 1,459 |
| 2026-02-15 | Wolk Joseph J | Exec VP, CFO | Convert | 1,878 |
| 2026-02-15 | Wolk Joseph J | Exec VP, CFO | Convert | 1,878 |
| 2026-02-15 | Wolk Joseph J | Exec VP, CFO | Tax | 858 |
| 2026-02-15 | Wolk Joseph J | Exec VP, CFO | Convert | 1,971 |
| 2026-02-15 | Wolk Joseph J | Exec VP, CFO | Tax | 817 |
| 2026-02-15 | Wolk Joseph J | Exec VP, CFO | Award | 3,863 |
| 2026-02-15 | Wolk Joseph J | Exec VP, CFO | Convert | 1,971 |
| 2026-02-15 | Wolk Joseph J | Exec VP, CFO | Award | 53,793 |
| 2026-02-15 | Decker Robert J | VP Corporate Controller | Convert | 339 |
| 2026-02-15 | Decker Robert J | VP Corporate Controller | Tax | 95 |
| 2026-02-15 | Decker Robert J | VP Corporate Controller | Award | 700 |
| 2026-02-15 | Decker Robert J | VP Corporate Controller | Convert | 339 |
| 2026-02-15 | Decker Robert J | VP Corporate Controller | Convert | 344 |
| 2026-02-15 | Decker Robert J | VP Corporate Controller | Award | 4,871 |